Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Complications of Medical Marijuana Use

By Dr. James W. Forsythe | December 16, 2015

Medical marijuana is now legal in 23 states and the District of Columbia, but that doesn’t mean it’s always clear sailing for patients who want or need to make use of the plant’s medicinal properties.

At times it’s a puzzle because what’s allowed in one state isn’t in another, and the federal government hasn’t budged on legalization. That creates barriers for patients.

“The fact that each state and the federal government have very different laws on marijuana makes things confusing,” says Dr. James W. Forsythe, an oncologist and author of the book Stoned: The Truth About Medical Marijuana and Hemp Oil.

Forsythe believes it’s important to cut through that confusion so that those who need marijuana for medicinal purposes can better understand its uses as well as its drawbacks.

He says that when used properly under a trained physician’s careful guidance, medicinal marijuana works wonders. But he also says there’s no doubt that some people fake their ailments because they want to enjoy the euphoric sensations marijuana makes possible.

“Using marijuana is generally safe for the vast majority of adults when used at moderate levels,” Forsythe says. “With this understood, consumers also need to realize that many people claim scientists still lack a full understanding of marijuana’s long-term effects.”

Pain is one of the conditions marijuana is most often used to treat. But it also can be prescribed for other ailments, such as muscle spasms caused by multiple sclerosis; nausea from cancer chemotherapy; poor appetite and weight loss caused by chronic illness, such as HIV; seizure disorders; and Crohn’s disease.

Forsythe says that, beyond dealing with the ailments themselves, patients who could benefit from medical marijuana face a number of issues:

  • Lack of insurance coverage. Insurance companies refuse to pay for drugs that have not been officially approved by the Food and Drug Administration for distribution in prescription form. That can create significant financial issues for the patients, Forsythe says.
  • Important research remains stalled. American scientists have expressed frustration that their research is hampered by the fact cannabis remains a Schedule I felony under federal law. “Fear of prosecution prevents formal, wide-scale and necessary studies on the apparent effectiveness of marijuana in treating specific diseases,” Forsythe says. The Brookings Institution released a research report in October that made just that point, and recommended a more comprehensive set of policy reforms that would liberate the medical community in its pursuit of marijuana research.
  • Bureaucracy hinders or blocks vital treatment. A variety of bureaucratic road bumps and roadblocks have caused countless people to be denied urgent medicinal marijuana treatments that might help them, Forsythe says. “As a society, we have essentially allowed government to fail the ailing people among us,” he says. “They endure needless suffering.”

One additional factor for some, Forsythe says, is that even though marijuana laws have been loosened in some states, many people still have a negative view of the plant.

“Ultimately, the possession and use of marijuana for medical purposes often becomes a personal decision,” he says. “Just as no one should ever be forced to consume alcohol, society should never require people to use marijuana.

“That said, consumers and patients everywhere should have a right to learn and to benefit from the many proven medical benefits marijuana provides.”

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE